nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—prostate cancer	0.185	0.466	CbGaD
Methoxsalen—CYP1A1—prostate cancer	0.13	0.326	CbGaD
Methoxsalen—CYP3A4—prostate cancer	0.0827	0.208	CbGaD
Methoxsalen—CYP1A1—Flutamide—prostate cancer	0.0616	0.166	CbGbCtD
Methoxsalen—CYP1A1—Estrone—prostate cancer	0.0445	0.12	CbGbCtD
Methoxsalen—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0331	0.0893	CbGbCtD
Methoxsalen—CYP1A2—Flutamide—prostate cancer	0.0275	0.0742	CbGbCtD
Methoxsalen—CYP1A1—Estradiol—prostate cancer	0.0256	0.0689	CbGbCtD
Methoxsalen—CYP1A2—Estrone—prostate cancer	0.0199	0.0536	CbGbCtD
Methoxsalen—CYP3A4—Bicalutamide—prostate cancer	0.0174	0.0469	CbGbCtD
Methoxsalen—CYP3A4—Estramustine—prostate cancer	0.0162	0.0436	CbGbCtD
Methoxsalen—CYP3A4—Abiraterone—prostate cancer	0.0144	0.0389	CbGbCtD
Methoxsalen—CYP3A4—Flutamide—prostate cancer	0.0144	0.0389	CbGbCtD
Methoxsalen—CYP1A2—Conjugated Estrogens—prostate cancer	0.013	0.0351	CbGbCtD
Methoxsalen—CYP1A2—Estradiol—prostate cancer	0.0114	0.0308	CbGbCtD
Methoxsalen—CYP3A4—Cabazitaxel—prostate cancer	0.0107	0.0287	CbGbCtD
Methoxsalen—CYP3A4—Estrone—prostate cancer	0.0104	0.0281	CbGbCtD
Methoxsalen—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00929	0.025	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—prostate cancer	0.00746	0.0201	CbGbCtD
Methoxsalen—CYP3A4—Conjugated Estrogens—prostate cancer	0.00682	0.0184	CbGbCtD
Methoxsalen—CYP3A4—Mitoxantrone—prostate cancer	0.0062	0.0167	CbGbCtD
Methoxsalen—CYP3A4—Estradiol—prostate cancer	0.00599	0.0161	CbGbCtD
Methoxsalen—CYP3A4—Prednisone—prostate cancer	0.00515	0.0139	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—prostate cancer	0.00391	0.0105	CbGbCtD
Methoxsalen—CYP3A4—Docetaxel—prostate cancer	0.00358	0.00964	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—prostate cancer	0.00267	0.00718	CbGbCtD
Methoxsalen—Oedema—Goserelin—prostate cancer	0.000179	0.00164	CcSEcCtD
Methoxsalen—Nausea—Cabazitaxel—prostate cancer	0.000178	0.00163	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—prostate cancer	0.000178	0.00163	CcSEcCtD
Methoxsalen—Infection—Goserelin—prostate cancer	0.000178	0.00163	CcSEcCtD
Methoxsalen—Oedema—Conjugated Estrogens—prostate cancer	0.000178	0.00162	CcSEcCtD
Methoxsalen—Infection—Conjugated Estrogens—prostate cancer	0.000176	0.00161	CcSEcCtD
Methoxsalen—Erythema—Estradiol—prostate cancer	0.000174	0.00159	CcSEcCtD
Methoxsalen—Skin disorder—Goserelin—prostate cancer	0.000174	0.00159	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—prostate cancer	0.000174	0.00159	CcSEcCtD
Methoxsalen—Urticaria—Ethinyl Estradiol—prostate cancer	0.000173	0.00158	CcSEcCtD
Methoxsalen—Skin disorder—Conjugated Estrogens—prostate cancer	0.000173	0.00158	CcSEcCtD
Methoxsalen—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000172	0.00157	CcSEcCtD
Methoxsalen—Tension—Estradiol—prostate cancer	0.000171	0.00156	CcSEcCtD
Methoxsalen—Dry skin—Docetaxel—prostate cancer	0.000171	0.00156	CcSEcCtD
Methoxsalen—Dysgeusia—Estradiol—prostate cancer	0.000171	0.00156	CcSEcCtD
Methoxsalen—Dizziness—Bicalutamide—prostate cancer	0.00017	0.00156	CcSEcCtD
Methoxsalen—Nervousness—Estradiol—prostate cancer	0.000169	0.00155	CcSEcCtD
Methoxsalen—Hypotension—Goserelin—prostate cancer	0.000168	0.00153	CcSEcCtD
Methoxsalen—Muscle spasms—Estradiol—prostate cancer	0.000167	0.00153	CcSEcCtD
Methoxsalen—Arrhythmia—Mitoxantrone—prostate cancer	0.000167	0.00152	CcSEcCtD
Methoxsalen—Hypotension—Conjugated Estrogens—prostate cancer	0.000166	0.00152	CcSEcCtD
Methoxsalen—Dry skin—Capecitabine—prostate cancer	0.000165	0.00151	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—prostate cancer	0.000165	0.00151	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—prostate cancer	0.000165	0.00151	CcSEcCtD
Methoxsalen—Rash—Bicalutamide—prostate cancer	0.000163	0.00149	CcSEcCtD
Methoxsalen—Dermatitis—Bicalutamide—prostate cancer	0.000162	0.00148	CcSEcCtD
Methoxsalen—Erythema—Mitoxantrone—prostate cancer	0.000162	0.00148	CcSEcCtD
Methoxsalen—Insomnia—Goserelin—prostate cancer	0.000162	0.00148	CcSEcCtD
Methoxsalen—Ill-defined disorder—Estradiol—prostate cancer	0.000162	0.00148	CcSEcCtD
Methoxsalen—Headache—Bicalutamide—prostate cancer	0.000161	0.00148	CcSEcCtD
Methoxsalen—Insomnia—Conjugated Estrogens—prostate cancer	0.000161	0.00147	CcSEcCtD
Methoxsalen—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000161	0.00147	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—prostate cancer	0.000159	0.00145	CcSEcCtD
Methoxsalen—Dysgeusia—Mitoxantrone—prostate cancer	0.000159	0.00145	CcSEcCtD
Methoxsalen—Dyspepsia—Goserelin—prostate cancer	0.000158	0.00144	CcSEcCtD
Methoxsalen—Malaise—Estradiol—prostate cancer	0.000157	0.00144	CcSEcCtD
Methoxsalen—Vertigo—Estradiol—prostate cancer	0.000156	0.00143	CcSEcCtD
Methoxsalen—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000156	0.00143	CcSEcCtD
Methoxsalen—Pruritus—Ethinyl Estradiol—prostate cancer	0.000154	0.00141	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000153	0.0014	CcSEcCtD
Methoxsalen—Nausea—Bicalutamide—prostate cancer	0.000153	0.0014	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—prostate cancer	0.000153	0.0014	CcSEcCtD
Methoxsalen—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000151	0.00138	CcSEcCtD
Methoxsalen—Feeling abnormal—Goserelin—prostate cancer	0.000148	0.00135	CcSEcCtD
Methoxsalen—Dry skin—Prednisone—prostate cancer	0.000147	0.00135	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—prostate cancer	0.000147	0.00134	CcSEcCtD
Methoxsalen—Discomfort—Estradiol—prostate cancer	0.000147	0.00134	CcSEcCtD
Methoxsalen—Malaise—Mitoxantrone—prostate cancer	0.000146	0.00134	CcSEcCtD
Methoxsalen—Dizziness—Ethinyl Estradiol—prostate cancer	0.000144	0.00132	CcSEcCtD
Methoxsalen—Urticaria—Goserelin—prostate cancer	0.000142	0.0013	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Capecitabine—prostate cancer	0.000142	0.0013	CcSEcCtD
Methoxsalen—Oedema—Estradiol—prostate cancer	0.000142	0.0013	CcSEcCtD
Methoxsalen—Body temperature increased—Goserelin—prostate cancer	0.000142	0.0013	CcSEcCtD
Methoxsalen—Infection—Estradiol—prostate cancer	0.000141	0.00129	CcSEcCtD
Methoxsalen—Urticaria—Conjugated Estrogens—prostate cancer	0.000141	0.00129	CcSEcCtD
Methoxsalen—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00014	0.00128	CcSEcCtD
Methoxsalen—Depression—Capecitabine—prostate cancer	0.000139	0.00127	CcSEcCtD
Methoxsalen—Skin disorder—Estradiol—prostate cancer	0.000138	0.00126	CcSEcCtD
Methoxsalen—Rash—Ethinyl Estradiol—prostate cancer	0.000137	0.00126	CcSEcCtD
Methoxsalen—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000137	0.00125	CcSEcCtD
Methoxsalen—Discomfort—Mitoxantrone—prostate cancer	0.000137	0.00125	CcSEcCtD
Methoxsalen—Headache—Ethinyl Estradiol—prostate cancer	0.000136	0.00125	CcSEcCtD
Methoxsalen—Oedema—Mitoxantrone—prostate cancer	0.000132	0.00121	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—prostate cancer	0.000132	0.00121	CcSEcCtD
Methoxsalen—Hypersensitivity—Goserelin—prostate cancer	0.000132	0.00121	CcSEcCtD
Methoxsalen—Infection—Mitoxantrone—prostate cancer	0.000132	0.0012	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—prostate cancer	0.000131	0.0012	CcSEcCtD
Methoxsalen—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000131	0.0012	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—prostate cancer	0.00013	0.00119	CcSEcCtD
Methoxsalen—Nausea—Ethinyl Estradiol—prostate cancer	0.000129	0.00118	CcSEcCtD
Methoxsalen—Skin disorder—Mitoxantrone—prostate cancer	0.000129	0.00118	CcSEcCtD
Methoxsalen—Insomnia—Estradiol—prostate cancer	0.000129	0.00118	CcSEcCtD
Methoxsalen—Pruritus—Goserelin—prostate cancer	0.000127	0.00116	CcSEcCtD
Methoxsalen—Pruritus—Conjugated Estrogens—prostate cancer	0.000126	0.00115	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—prostate cancer	0.000125	0.00114	CcSEcCtD
Methoxsalen—Dyspepsia—Estradiol—prostate cancer	0.000125	0.00114	CcSEcCtD
Methoxsalen—Hypotension—Mitoxantrone—prostate cancer	0.000124	0.00113	CcSEcCtD
Methoxsalen—Depression—Prednisone—prostate cancer	0.000123	0.00113	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Estradiol—prostate cancer	0.000123	0.00112	CcSEcCtD
Methoxsalen—Malaise—Etoposide—prostate cancer	0.000122	0.00111	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—prostate cancer	0.000122	0.00111	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—prostate cancer	0.000121	0.00111	CcSEcCtD
Methoxsalen—Dizziness—Goserelin—prostate cancer	0.000119	0.00108	CcSEcCtD
Methoxsalen—Dizziness—Conjugated Estrogens—prostate cancer	0.000117	0.00107	CcSEcCtD
Methoxsalen—Feeling abnormal—Estradiol—prostate cancer	0.000117	0.00107	CcSEcCtD
Methoxsalen—Dyspepsia—Mitoxantrone—prostate cancer	0.000117	0.00107	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—prostate cancer	0.000115	0.00105	CcSEcCtD
Methoxsalen—Arrhythmia—Docetaxel—prostate cancer	0.000115	0.00105	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—prostate cancer	0.000114	0.00104	CcSEcCtD
Methoxsalen—Rash—Goserelin—prostate cancer	0.000113	0.00103	CcSEcCtD
Methoxsalen—Dermatitis—Goserelin—prostate cancer	0.000113	0.00103	CcSEcCtD
Methoxsalen—Urticaria—Estradiol—prostate cancer	0.000113	0.00103	CcSEcCtD
Methoxsalen—Body temperature increased—Estradiol—prostate cancer	0.000112	0.00103	CcSEcCtD
Methoxsalen—Headache—Goserelin—prostate cancer	0.000112	0.00103	CcSEcCtD
Methoxsalen—Erythema—Docetaxel—prostate cancer	0.000112	0.00103	CcSEcCtD
Methoxsalen—Rash—Conjugated Estrogens—prostate cancer	0.000112	0.00102	CcSEcCtD
Methoxsalen—Dermatitis—Conjugated Estrogens—prostate cancer	0.000112	0.00102	CcSEcCtD
Methoxsalen—Arrhythmia—Capecitabine—prostate cancer	0.000111	0.00102	CcSEcCtD
Methoxsalen—Headache—Conjugated Estrogens—prostate cancer	0.000111	0.00102	CcSEcCtD
Methoxsalen—Dysgeusia—Docetaxel—prostate cancer	0.00011	0.001	CcSEcCtD
Methoxsalen—Infection—Etoposide—prostate cancer	0.000109	0.001	CcSEcCtD
Methoxsalen—Feeling abnormal—Mitoxantrone—prostate cancer	0.000109	0.000998	CcSEcCtD
Methoxsalen—Erythema—Capecitabine—prostate cancer	0.000109	0.000993	CcSEcCtD
Methoxsalen—Muscle spasms—Docetaxel—prostate cancer	0.000108	0.000986	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—prostate cancer	0.000107	0.000978	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—prostate cancer	0.000107	0.000974	CcSEcCtD
Methoxsalen—Nausea—Goserelin—prostate cancer	0.000107	0.000973	CcSEcCtD
Methoxsalen—Dysgeusia—Capecitabine—prostate cancer	0.000106	0.000972	CcSEcCtD
Methoxsalen—Nausea—Conjugated Estrogens—prostate cancer	0.000106	0.000964	CcSEcCtD
Methoxsalen—Urticaria—Mitoxantrone—prostate cancer	0.000105	0.000962	CcSEcCtD
Methoxsalen—Hypersensitivity—Estradiol—prostate cancer	0.000105	0.000957	CcSEcCtD
Methoxsalen—Body temperature increased—Mitoxantrone—prostate cancer	0.000105	0.000957	CcSEcCtD
Methoxsalen—Muscle spasms—Capecitabine—prostate cancer	0.000104	0.000954	CcSEcCtD
Methoxsalen—Hypotension—Etoposide—prostate cancer	0.000103	0.000941	CcSEcCtD
Methoxsalen—Ill-defined disorder—Capecitabine—prostate cancer	0.000101	0.000921	CcSEcCtD
Methoxsalen—Pruritus—Estradiol—prostate cancer	0.000101	0.000919	CcSEcCtD
Methoxsalen—Arrhythmia—Prednisone—prostate cancer	9.93e-05	0.000907	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—prostate cancer	9.91e-05	0.000906	CcSEcCtD
Methoxsalen—Malaise—Capecitabine—prostate cancer	9.8e-05	0.000895	CcSEcCtD
Methoxsalen—Vertigo—Capecitabine—prostate cancer	9.76e-05	0.000892	CcSEcCtD
Methoxsalen—Hypersensitivity—Mitoxantrone—prostate cancer	9.76e-05	0.000892	CcSEcCtD
Methoxsalen—Erythema—Prednisone—prostate cancer	9.68e-05	0.000884	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—prostate cancer	9.51e-05	0.000869	CcSEcCtD
Methoxsalen—Dizziness—Estradiol—prostate cancer	9.4e-05	0.000859	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—prostate cancer	9.17e-05	0.000838	CcSEcCtD
Methoxsalen—Oedema—Docetaxel—prostate cancer	9.16e-05	0.000837	CcSEcCtD
Methoxsalen—Discomfort—Capecitabine—prostate cancer	9.14e-05	0.000835	CcSEcCtD
Methoxsalen—Infection—Docetaxel—prostate cancer	9.1e-05	0.000831	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—prostate cancer	9.08e-05	0.00083	CcSEcCtD
Methoxsalen—Ill-defined disorder—Prednisone—prostate cancer	8.98e-05	0.00082	CcSEcCtD
Methoxsalen—Rash—Estradiol—prostate cancer	8.96e-05	0.000819	CcSEcCtD
Methoxsalen—Dermatitis—Estradiol—prostate cancer	8.95e-05	0.000818	CcSEcCtD
Methoxsalen—Headache—Estradiol—prostate cancer	8.91e-05	0.000814	CcSEcCtD
Methoxsalen—Skin disorder—Docetaxel—prostate cancer	8.89e-05	0.000813	CcSEcCtD
Methoxsalen—Oedema—Capecitabine—prostate cancer	8.87e-05	0.00081	CcSEcCtD
Methoxsalen—Infection—Capecitabine—prostate cancer	8.81e-05	0.000805	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—prostate cancer	8.75e-05	0.0008	CcSEcCtD
Methoxsalen—Malaise—Prednisone—prostate cancer	8.73e-05	0.000797	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—prostate cancer	8.71e-05	0.000796	CcSEcCtD
Methoxsalen—Vertigo—Prednisone—prostate cancer	8.69e-05	0.000794	CcSEcCtD
Methoxsalen—Skin disorder—Capecitabine—prostate cancer	8.61e-05	0.000787	CcSEcCtD
Methoxsalen—Hypotension—Docetaxel—prostate cancer	8.56e-05	0.000782	CcSEcCtD
Methoxsalen—Nausea—Estradiol—prostate cancer	8.44e-05	0.000772	CcSEcCtD
Methoxsalen—Rash—Mitoxantrone—prostate cancer	8.35e-05	0.000763	CcSEcCtD
Methoxsalen—Dermatitis—Mitoxantrone—prostate cancer	8.34e-05	0.000763	CcSEcCtD
Methoxsalen—Headache—Mitoxantrone—prostate cancer	8.3e-05	0.000758	CcSEcCtD
Methoxsalen—Hypotension—Capecitabine—prostate cancer	8.28e-05	0.000757	CcSEcCtD
Methoxsalen—Insomnia—Docetaxel—prostate cancer	8.28e-05	0.000757	CcSEcCtD
Methoxsalen—Discomfort—Prednisone—prostate cancer	8.14e-05	0.000744	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—prostate cancer	8.12e-05	0.000742	CcSEcCtD
Methoxsalen—Dyspepsia—Docetaxel—prostate cancer	8.06e-05	0.000737	CcSEcCtD
Methoxsalen—Insomnia—Capecitabine—prostate cancer	8.02e-05	0.000733	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Docetaxel—prostate cancer	7.9e-05	0.000722	CcSEcCtD
Methoxsalen—Oedema—Prednisone—prostate cancer	7.9e-05	0.000722	CcSEcCtD
Methoxsalen—Nausea—Mitoxantrone—prostate cancer	7.87e-05	0.000719	CcSEcCtD
Methoxsalen—Infection—Prednisone—prostate cancer	7.84e-05	0.000717	CcSEcCtD
Methoxsalen—Dyspepsia—Capecitabine—prostate cancer	7.8e-05	0.000713	CcSEcCtD
Methoxsalen—Pruritus—Etoposide—prostate cancer	7.79e-05	0.000712	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—prostate cancer	7.77e-05	0.00071	CcSEcCtD
Methoxsalen—Skin disorder—Prednisone—prostate cancer	7.67e-05	0.000701	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Capecitabine—prostate cancer	7.65e-05	0.000699	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—prostate cancer	7.57e-05	0.000692	CcSEcCtD
Methoxsalen—Feeling abnormal—Docetaxel—prostate cancer	7.55e-05	0.00069	CcSEcCtD
Methoxsalen—Tension—Epirubicin—prostate cancer	7.43e-05	0.000679	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—prostate cancer	7.41e-05	0.000677	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—prostate cancer	7.35e-05	0.000672	CcSEcCtD
Methoxsalen—Feeling abnormal—Capecitabine—prostate cancer	7.31e-05	0.000668	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—prostate cancer	7.29e-05	0.000666	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—prostate cancer	7.28e-05	0.000665	CcSEcCtD
Methoxsalen—Body temperature increased—Docetaxel—prostate cancer	7.24e-05	0.000662	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—prostate cancer	7.19e-05	0.000657	CcSEcCtD
Methoxsalen—Insomnia—Prednisone—prostate cancer	7.14e-05	0.000653	CcSEcCtD
Methoxsalen—Urticaria—Capecitabine—prostate cancer	7.04e-05	0.000644	CcSEcCtD
Methoxsalen—Ill-defined disorder—Epirubicin—prostate cancer	7.02e-05	0.000642	CcSEcCtD
Methoxsalen—Body temperature increased—Capecitabine—prostate cancer	7.01e-05	0.00064	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—prostate cancer	7e-05	0.00064	CcSEcCtD
Methoxsalen—Dyspepsia—Prednisone—prostate cancer	6.95e-05	0.000635	CcSEcCtD
Methoxsalen—Rash—Etoposide—prostate cancer	6.95e-05	0.000635	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—prostate cancer	6.94e-05	0.000634	CcSEcCtD
Methoxsalen—Headache—Etoposide—prostate cancer	6.9e-05	0.000631	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—prostate cancer	6.87e-05	0.000628	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—prostate cancer	6.86e-05	0.000627	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—prostate cancer	6.82e-05	0.000624	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—prostate cancer	6.8e-05	0.000622	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—prostate cancer	6.8e-05	0.000621	CcSEcCtD
Methoxsalen—Hypersensitivity—Docetaxel—prostate cancer	6.75e-05	0.000617	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—prostate cancer	6.73e-05	0.000615	CcSEcCtD
Methoxsalen—Nausea—Etoposide—prostate cancer	6.54e-05	0.000598	CcSEcCtD
Methoxsalen—Hypersensitivity—Capecitabine—prostate cancer	6.53e-05	0.000597	CcSEcCtD
Methoxsalen—Feeling abnormal—Prednisone—prostate cancer	6.51e-05	0.000595	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—prostate cancer	6.5e-05	0.000594	CcSEcCtD
Methoxsalen—Pruritus—Docetaxel—prostate cancer	6.48e-05	0.000592	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—prostate cancer	6.37e-05	0.000582	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—prostate cancer	6.31e-05	0.000577	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—prostate cancer	6.29e-05	0.000575	CcSEcCtD
Methoxsalen—Urticaria—Prednisone—prostate cancer	6.27e-05	0.000573	CcSEcCtD
Methoxsalen—Pruritus—Capecitabine—prostate cancer	6.27e-05	0.000573	CcSEcCtD
Methoxsalen—Body temperature increased—Prednisone—prostate cancer	6.24e-05	0.000571	CcSEcCtD
Methoxsalen—Oedema—Epirubicin—prostate cancer	6.18e-05	0.000564	CcSEcCtD
Methoxsalen—Infection—Epirubicin—prostate cancer	6.14e-05	0.000561	CcSEcCtD
Methoxsalen—Dizziness—Docetaxel—prostate cancer	6.05e-05	0.000553	CcSEcCtD
Methoxsalen—Skin disorder—Epirubicin—prostate cancer	6e-05	0.000548	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—prostate cancer	5.89e-05	0.000538	CcSEcCtD
Methoxsalen—Dizziness—Capecitabine—prostate cancer	5.86e-05	0.000536	CcSEcCtD
Methoxsalen—Hypersensitivity—Prednisone—prostate cancer	5.82e-05	0.000532	CcSEcCtD
Methoxsalen—Rash—Docetaxel—prostate cancer	5.77e-05	0.000528	CcSEcCtD
Methoxsalen—Hypotension—Epirubicin—prostate cancer	5.77e-05	0.000527	CcSEcCtD
Methoxsalen—Dermatitis—Docetaxel—prostate cancer	5.77e-05	0.000527	CcSEcCtD
Methoxsalen—Headache—Docetaxel—prostate cancer	5.74e-05	0.000524	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—prostate cancer	5.71e-05	0.000522	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—prostate cancer	5.68e-05	0.000519	CcSEcCtD
Methoxsalen—Rash—Capecitabine—prostate cancer	5.59e-05	0.000511	CcSEcCtD
Methoxsalen—Pruritus—Prednisone—prostate cancer	5.59e-05	0.000511	CcSEcCtD
Methoxsalen—Insomnia—Epirubicin—prostate cancer	5.59e-05	0.000511	CcSEcCtD
Methoxsalen—Dermatitis—Capecitabine—prostate cancer	5.58e-05	0.00051	CcSEcCtD
Methoxsalen—Headache—Capecitabine—prostate cancer	5.55e-05	0.000508	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—prostate cancer	5.55e-05	0.000507	CcSEcCtD
Methoxsalen—Nausea—Docetaxel—prostate cancer	5.44e-05	0.000497	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—prostate cancer	5.44e-05	0.000497	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—prostate cancer	5.34e-05	0.000488	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—prostate cancer	5.33e-05	0.000487	CcSEcCtD
Methoxsalen—Nausea—Capecitabine—prostate cancer	5.27e-05	0.000481	CcSEcCtD
Methoxsalen—Dizziness—Prednisone—prostate cancer	5.22e-05	0.000477	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—prostate cancer	5.17e-05	0.000472	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—prostate cancer	5.09e-05	0.000465	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—prostate cancer	5.03e-05	0.00046	CcSEcCtD
Methoxsalen—Rash—Prednisone—prostate cancer	4.98e-05	0.000455	CcSEcCtD
Methoxsalen—Dermatitis—Prednisone—prostate cancer	4.97e-05	0.000455	CcSEcCtD
Methoxsalen—Headache—Prednisone—prostate cancer	4.95e-05	0.000452	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.93e-05	0.000451	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—prostate cancer	4.91e-05	0.000448	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—prostate cancer	4.88e-05	0.000446	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—prostate cancer	4.71e-05	0.00043	CcSEcCtD
Methoxsalen—Nausea—Prednisone—prostate cancer	4.69e-05	0.000429	CcSEcCtD
Methoxsalen—Hypersensitivity—Epirubicin—prostate cancer	4.55e-05	0.000416	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—prostate cancer	4.54e-05	0.000415	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—prostate cancer	4.52e-05	0.000413	CcSEcCtD
Methoxsalen—Pruritus—Epirubicin—prostate cancer	4.37e-05	0.000399	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—prostate cancer	4.21e-05	0.000385	CcSEcCtD
Methoxsalen—Dizziness—Epirubicin—prostate cancer	4.08e-05	0.000373	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—prostate cancer	4.04e-05	0.000369	CcSEcCtD
Methoxsalen—Rash—Epirubicin—prostate cancer	3.89e-05	0.000356	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—prostate cancer	3.89e-05	0.000356	CcSEcCtD
Methoxsalen—Headache—Epirubicin—prostate cancer	3.87e-05	0.000354	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—prostate cancer	3.78e-05	0.000345	CcSEcCtD
Methoxsalen—Nausea—Epirubicin—prostate cancer	3.67e-05	0.000335	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—prostate cancer	3.6e-05	0.000329	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—prostate cancer	3.6e-05	0.000329	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—prostate cancer	3.58e-05	0.000327	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—prostate cancer	3.39e-05	0.00031	CcSEcCtD
Methoxsalen—CYP2A6—Metabolism—CYP2E1—prostate cancer	5.57e-06	4.55e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GNG5—prostate cancer	5.54e-06	4.52e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NQO1—prostate cancer	5.5e-06	4.5e-05	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PIK3CA—prostate cancer	5.45e-06	4.46e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD17B1—prostate cancer	5.45e-06	4.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.45e-06	4.45e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—TH—prostate cancer	5.42e-06	4.43e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.37e-06	4.39e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP3A4—prostate cancer	5.37e-06	4.38e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACSL4—prostate cancer	5.35e-06	4.37e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD17B3—prostate cancer	5.35e-06	4.37e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NCOA3—prostate cancer	5.33e-06	4.36e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.29e-06	4.32e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1B1—prostate cancer	5.28e-06	4.31e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.24e-06	4.28e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PHGDH—prostate cancer	5.13e-06	4.19e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—UMPS—prostate cancer	5.13e-06	4.19e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ARG2—prostate cancer	5.13e-06	4.19e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GGT1—prostate cancer	5.11e-06	4.17e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.11e-06	4.17e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—HPGDS—prostate cancer	5.09e-06	4.16e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP2C19—prostate cancer	5.06e-06	4.13e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NCOA1—prostate cancer	5.03e-06	4.11e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LDHB—prostate cancer	5.03e-06	4.11e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP19A1—prostate cancer	4.96e-06	4.05e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP3A5—prostate cancer	4.94e-06	4.04e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTT1—prostate cancer	4.93e-06	4.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ACHE—prostate cancer	4.93e-06	4.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP2A6—prostate cancer	4.88e-06	3.98e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.86e-06	3.97e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HPGD—prostate cancer	4.86e-06	3.97e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.86e-06	3.97e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—RXRA—prostate cancer	4.79e-06	3.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TCN2—prostate cancer	4.77e-06	3.9e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—UCP3—prostate cancer	4.77e-06	3.9e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PDHA1—prostate cancer	4.77e-06	3.9e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTA3—prostate cancer	4.77e-06	3.9e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKR1C3—prostate cancer	4.74e-06	3.88e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PRKACB—prostate cancer	4.72e-06	3.86e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP17A1—prostate cancer	4.67e-06	3.82e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—COMT—prostate cancer	4.61e-06	3.77e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.61e-06	3.76e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTP1—prostate cancer	4.59e-06	3.75e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.57e-06	3.73e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC22A3—prostate cancer	4.55e-06	3.72e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD3B1—prostate cancer	4.55e-06	3.72e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ITPR1—prostate cancer	4.52e-06	3.69e-05	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—AKT1—prostate cancer	4.46e-06	3.64e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NCOA2—prostate cancer	4.45e-06	3.64e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTAP—prostate cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.42e-06	3.61e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TBXAS1—prostate cancer	4.36e-06	3.57e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTA4—prostate cancer	4.36e-06	3.57e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.33e-06	3.54e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.33e-06	3.54e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—TYMS—prostate cancer	4.27e-06	3.49e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.27e-06	3.48e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTA2—prostate cancer	4.25e-06	3.47e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC5A5—prostate cancer	4.25e-06	3.47e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTM1—prostate cancer	4.22e-06	3.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ABCG5—prostate cancer	4.2e-06	3.43e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SULT1A1—prostate cancer	4.2e-06	3.43e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP2E1—prostate cancer	4.15e-06	3.39e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—LPL—prostate cancer	4.14e-06	3.38e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.13e-06	3.38e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACSL4—prostate cancer	4.13e-06	3.38e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTA1—prostate cancer	4.1e-06	3.35e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NQO1—prostate cancer	4.1e-06	3.35e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTO1—prostate cancer	4.06e-06	3.31e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NAT2—prostate cancer	4.06e-06	3.31e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD3B2—prostate cancer	4.06e-06	3.31e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—TH—prostate cancer	4.04e-06	3.3e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.02e-06	3.28e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP3A4—prostate cancer	4e-06	3.27e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A1—prostate cancer	4e-06	3.27e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.98e-06	3.25e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ERCC2—prostate cancer	3.97e-06	3.24e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—UMPS—prostate cancer	3.96e-06	3.24e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PHGDH—prostate cancer	3.96e-06	3.24e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ARG2—prostate cancer	3.96e-06	3.24e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP1B1—prostate cancer	3.93e-06	3.21e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.9e-06	3.19e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LRP2—prostate cancer	3.89e-06	3.18e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PLCB2—prostate cancer	3.89e-06	3.18e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2C18—prostate cancer	3.89e-06	3.18e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LDHB—prostate cancer	3.88e-06	3.17e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—P4HB—prostate cancer	3.81e-06	3.12e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.81e-06	3.12e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GGT1—prostate cancer	3.81e-06	3.11e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NCOA1—prostate cancer	3.75e-06	3.06e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—MTHFR—prostate cancer	3.73e-06	3.05e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.71e-06	3.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP19A1—prostate cancer	3.7e-06	3.02e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PDHA1—prostate cancer	3.68e-06	3.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTA3—prostate cancer	3.68e-06	3.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TCN2—prostate cancer	3.68e-06	3.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—UCP3—prostate cancer	3.68e-06	3.01e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.67e-06	3e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPARA—prostate cancer	3.66e-06	2.99e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.62e-06	2.95e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—RXRA—prostate cancer	3.57e-06	2.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MED12—prostate cancer	3.56e-06	2.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GNG5—prostate cancer	3.53e-06	2.88e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.51e-06	2.87e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.47e-06	2.83e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CAV1—prostate cancer	3.44e-06	2.81e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—COMT—prostate cancer	3.44e-06	2.81e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTP1—prostate cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NCOA3—prostate cancer	3.4e-06	2.78e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTA4—prostate cancer	3.37e-06	2.75e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.37e-06	2.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ITPR1—prostate cancer	3.37e-06	2.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.34e-06	2.73e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.31e-06	2.7e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTA2—prostate cancer	3.28e-06	2.68e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HPGDS—prostate cancer	3.24e-06	2.65e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.24e-06	2.65e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ABCG5—prostate cancer	3.24e-06	2.65e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.22e-06	2.63e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—TYMS—prostate cancer	3.18e-06	2.6e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTA1—prostate cancer	3.17e-06	2.59e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACHE—prostate cancer	3.15e-06	2.57e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTT1—prostate cancer	3.15e-06	2.57e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTM1—prostate cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CG—prostate cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTO1—prostate cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NAT2—prostate cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.11e-06	2.54e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.1e-06	2.53e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—LPL—prostate cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.03e-06	2.47e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PRKACB—prostate cancer	3.01e-06	2.46e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PLCB2—prostate cancer	3e-06	2.45e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LRP2—prostate cancer	3e-06	2.45e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2C18—prostate cancer	3e-06	2.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.98e-06	2.43e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—INS—prostate cancer	2.96e-06	2.42e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ERCC2—prostate cancer	2.95e-06	2.41e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—P4HB—prostate cancer	2.94e-06	2.41e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.94e-06	2.4e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CREBBP—prostate cancer	2.9e-06	2.37e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NCOA2—prostate cancer	2.84e-06	2.32e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.79e-06	2.28e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MTHFR—prostate cancer	2.78e-06	2.27e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.75e-06	2.25e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MED12—prostate cancer	2.75e-06	2.24e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPARA—prostate cancer	2.73e-06	2.23e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GNG5—prostate cancer	2.72e-06	2.23e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.71e-06	2.21e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.64e-06	2.16e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NCOA3—prostate cancer	2.62e-06	2.14e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NQO1—prostate cancer	2.61e-06	2.14e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NOS3—prostate cancer	2.6e-06	2.12e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TH—prostate cancer	2.58e-06	2.11e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CAV1—prostate cancer	2.56e-06	2.09e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.56e-06	2.09e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.55e-06	2.08e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.54e-06	2.07e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.51e-06	2.05e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HPGDS—prostate cancer	2.5e-06	2.05e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.49e-06	2.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.45e-06	2e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTT1—prostate cancer	2.43e-06	1.98e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACHE—prostate cancer	2.43e-06	1.98e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GGT1—prostate cancer	2.43e-06	1.98e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CB—prostate cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NCOA1—prostate cancer	2.39e-06	1.95e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTGS2—prostate cancer	2.38e-06	1.94e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.36e-06	1.93e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.33e-06	1.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CG—prostate cancer	2.33e-06	1.91e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PRKACB—prostate cancer	2.32e-06	1.9e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—RXRA—prostate cancer	2.27e-06	1.86e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.21e-06	1.81e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—INS—prostate cancer	2.21e-06	1.8e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—COMT—prostate cancer	2.19e-06	1.79e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NCOA2—prostate cancer	2.19e-06	1.79e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTP1—prostate cancer	2.18e-06	1.78e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CREBBP—prostate cancer	2.16e-06	1.77e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ITPR1—prostate cancer	2.15e-06	1.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.11e-06	1.72e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.09e-06	1.71e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTEN—prostate cancer	2.07e-06	1.69e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.05e-06	1.68e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.04e-06	1.67e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TYMS—prostate cancer	2.03e-06	1.66e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NQO1—prostate cancer	2.02e-06	1.65e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTM1—prostate cancer	2e-06	1.64e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TH—prostate cancer	1.99e-06	1.62e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—EP300—prostate cancer	1.98e-06	1.62e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LPL—prostate cancer	1.97e-06	1.61e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NOS3—prostate cancer	1.94e-06	1.58e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.93e-06	1.58e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.9e-06	1.55e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ERCC2—prostate cancer	1.88e-06	1.54e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GGT1—prostate cancer	1.87e-06	1.53e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NCOA1—prostate cancer	1.85e-06	1.51e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.82e-06	1.49e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.79e-06	1.46e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTGS2—prostate cancer	1.77e-06	1.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MTHFR—prostate cancer	1.77e-06	1.45e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—RXRA—prostate cancer	1.76e-06	1.43e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPARA—prostate cancer	1.74e-06	1.42e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—COMT—prostate cancer	1.69e-06	1.38e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTP1—prostate cancer	1.68e-06	1.37e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ITPR1—prostate cancer	1.66e-06	1.35e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CAV1—prostate cancer	1.63e-06	1.33e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TYMS—prostate cancer	1.56e-06	1.28e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.56e-06	1.28e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTM1—prostate cancer	1.55e-06	1.26e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTEN—prostate cancer	1.55e-06	1.26e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LPL—prostate cancer	1.52e-06	1.24e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.49e-06	1.22e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—EP300—prostate cancer	1.47e-06	1.2e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.2e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.46e-06	1.2e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ERCC2—prostate cancer	1.45e-06	1.19e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—INS—prostate cancer	1.41e-06	1.15e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CREBBP—prostate cancer	1.38e-06	1.13e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTHFR—prostate cancer	1.37e-06	1.12e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPARA—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.31e-06	1.07e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CAV1—prostate cancer	1.26e-06	1.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NOS3—prostate cancer	1.24e-06	1.01e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKT1—prostate cancer	1.2e-06	9.76e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.15e-06	9.38e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.14e-06	9.31e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTGS2—prostate cancer	1.13e-06	9.23e-06	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.09e-06	8.91e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—INS—prostate cancer	1.09e-06	8.88e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CREBBP—prostate cancer	1.06e-06	8.7e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.01e-06	8.25e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTEN—prostate cancer	9.85e-07	8.05e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NOS3—prostate cancer	9.53e-07	7.79e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—EP300—prostate cancer	9.4e-07	7.68e-06	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKT1—prostate cancer	8.91e-07	7.28e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.8e-07	7.19e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGS2—prostate cancer	8.72e-07	7.12e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTEN—prostate cancer	7.6e-07	6.21e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—EP300—prostate cancer	7.25e-07	5.92e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.95e-07	5.68e-06	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKT1—prostate cancer	5.68e-07	4.64e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.36e-07	4.38e-06	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKT1—prostate cancer	4.38e-07	3.58e-06	CbGpPWpGaD
